Mr. Moorin is a founding General Partner at ProQuest. He is a healthcare executive with senior management experience in biotech, investment banking and pharmaceutical industry. Prior to founding ProQuest, Mr. Moorin served as CEO of Magainin Pharmaceuticals (now Genaera Corp.). Previously, he was Managing Director of Health Care Banking at Bear, Stearns & Co. Mr. Moorin has also held various positions in strategy and general management at E.R. Squibb & Sons Pharmaceuticals. He has served on the Board of Directors of ACMI, Epic Therapeutics, Guava Technologies, Mersana Therapeutics, Novacea (now Transcept) and Pharmion. Currently, Mr. Moorin serves on the Board of Directors of Acurian, Aires Pharmaceuticals, Eagle Pharmaceutical, Gloucester Pharmaceuticals and MethylGene.

Mr. Moorin holds the position of Adjunct Senior Fellow of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. He received a B.A. in economics with distinction from the University of Michigan.